MEDICAL TREATMENT IN MYOMA UTERINE: A LITERATURE REVIEW

Myoma uterine was regarded as a serious public health issue that has a substantial financial, social, and medical impact on both patients and the healthcare system. It affects many women of reproductive ages. Approriate management is needed to treat the myoma uterine. In this review, we will describe about medical treatment in myoma uterine. This study was literature review which carried out from August to September 2024 through literature sources in the form of textbooks, clinical guidelines, and online scientific journals from the last 5 years. Based on the literature study, it was found that there are several therapies for uterine myoma including oral contraceptives (OCs), gonadotrophin-releasing hormone (GnRH) agonist and antagonist, levonorgestrel-releasing intrauterine system (LNG-IUS), progestin-releasing intrauterine device (IUD), selective progesterone receptor modulators (SPRMs), aromatase inhibitors (AIs), tranexamic acid, and nonsteroidal anti-inflammatory drugs (NSAIDs).